Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar
Although there was an observed increase in resource utilization resulting from clinical pharmacists' interventions, this study highlights their crucial role in mitigating the costs associated with preventable adverse drug events.
Authors
- Daoud Al‐Badriyeh (ORCID: https://orcid.org/0000-0001-7791-954X)
- Wessam Elkassem (ORCID: https://orcid.org/0000-0003-2145-7555)
- Binny Thomas (ORCID: https://orcid.org/0000-0003-1065-8343)
- Syed M. Shahid (ORCID: https://orcid.org/0000-0003-0185-9362)
- Shimaa Aboelbaha (ORCID: https://orcid.org/0000-0003-3900-4415)
- Dina Abushanab (ORCID: https://orcid.org/0000-0002-4162-8617)
- Islam Eljilany (ORCID: https://orcid.org/0000-0001-6387-5419)
- Noor Alsalemi (ORCID: https://orcid.org/0000-0002-7819-7064)
- Nurhan ElShafey
- Palli Valapila Abdulrouf
- Moza Al Hail
Institutions
- Moffitt Cancer Center (US)
- Hamad bin Khalifa University (QA)
- Hamad Medical Corporation (QA)
- Qatar University (QA)
Publication Details
- Journal
- International Journal of Clinical Pharmacy
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1007/s11096-025-01933-z
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.22
Funders
- Hamad Medical Corporation
- Qatar National Library
- Medical Research Council